Pathstone Family Office’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-40,950	Closed	-$1.47M	–	705
2019 Q2	$1.47M	Buy	+40,950	New	+$1.47M	0.17%	64
2019 Q1	–	Sell	-38,700	Closed	-$1.67M	–	943
2018 Q4	$1.67M	Buy	+38,700	New	+$1.67M	0.48%	24